HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Auditory neuropathy, optic atrophy syndrome — Clinical Guidelines

Overview

Auditory neuropathy spectrum disorder (ANSD) is a heterogeneous form of sensorineural hearing impairment characterized by normal outer hair cell function but abnormal neural transmission in the auditory pathway. This condition leads to significant challenges in speech perception, particularly in noisy environments, despite relatively normal or near-normal hearing thresholds on pure-tone audiometry. ANSD predominantly affects infants and children, though it can occur at any age. Early identification and intervention are crucial due to the profound impact on language development and educational outcomes. Understanding ANSD is essential for clinicians to tailor appropriate management strategies and support affected individuals effectively 1 5 6 11.

Pathophysiology

ANSD arises from disruptions in the neural transmission of auditory signals, often due to dys-synchronous firing of auditory nerve fibers or impaired phase locking abilities. The underlying mechanisms can vary widely, including genetic mutations affecting genes such as OTOF (otoferlin), PJVK (previously known as CABP2), and NFASC (neurofascin), which are crucial for synaptic transmission and neural function in the cochlea 1 5 28. These genetic alterations can impact the inner hair cells, their synapses with the auditory nerve, or the auditory nerve fibers themselves. Consequently, while outer hair cells may function normally, the neural encoding of sound is compromised, leading to difficulties in processing temporal aspects of speech and environmental sounds 3 4 11.

Epidemiology

The prevalence of ANSD among individuals with sensorineural hearing loss (SNHL) ranges from 2.4% to 15%, indicating its significant but variable occurrence 5 6. ANSD can affect individuals of any age, but it is notably prevalent in pediatric populations, with estimates suggesting that approximately 10%–15% of congenital SNHL cases present with this disorder 6 11. Geographic and ethnic variations in prevalence have been noted, with certain genetic mutations more common in specific populations, such as OTOF mutations in Chinese patients 1 28. Over time, advancements in genetic testing and diagnostic techniques have improved the identification of ANSD, potentially leading to more accurate prevalence data 1 5.

Clinical Presentation

Children with ANSD typically present with difficulties in speech perception, particularly in challenging listening environments, despite having relatively normal hearing thresholds on pure-tone audiometry. Common symptoms include:

Poor speech discrimination

Difficulty understanding speech in noisy settings

Fluctuating hearing sensitivity

Normal or near-normal otoacoustic emissions (OAEs) and cochlear microphonics (CMs)

Absent or abnormal auditory brainstem responses (ABRs)

Red-flag features that warrant further investigation include:

Family history of hearing impairment

Associated neurological or systemic symptoms (e.g., hypotonia, respiratory insufficiency)

Delayed language development

These presentations necessitate a thorough diagnostic evaluation to confirm ANSD and rule out other causes of hearing impairment 3 6 11.

Diagnosis

The diagnosis of ANSD involves a comprehensive audiological evaluation to identify the characteristic pattern of preserved outer hair cell function alongside abnormal neural transmission. Key diagnostic criteria and tests include:

Otoacoustic Emissions (OAEs): Normal or near-normal OAEs indicating intact outer hair cells.

Cochlear Microphonics (CMs): Normal CMs further supporting outer hair cell function.

Auditory Brainstem Responses (ABRs): Absent or markedly abnormal ABRs, indicating neural transmission issues.

Temporal Processing Tests: Abnormal gap detection thresholds and modulation detection, reflecting impaired temporal processing.

Behavioral Auditory Processing Tests: Poor performance on speech perception tasks relative to audiometric thresholds.

Differential Diagnosis:

Sensorineural Hearing Loss (SNHL): Typically shows abnormal OAEs and ABRs, unlike ANSD where OAEs are often preserved.

Auditory Processing Disorder (APD): Focuses more on central auditory processing deficits without the characteristic audiological profile of ANSD.

Mixed Hearing Loss: Combination of conductive and sensorineural components, often with different audiometric patterns 3 6 11.

Management

Initial Management

Audiological Interventions:

Hearing Aids: Utilize specialized amplification strategies such as low-cut filters and frequency-specific processing to enhance temporal cues.

Cochlear Implantation: Considered for severe to profound cases where hearing aids are insufficient, especially in children 9 11 22.

Speech and Language Therapy:

Early intervention programs focusing on auditory-verbal therapy to optimize speech and language development.

Use of visual and tactile cues to support communication skills 11 27.

Second-Line Management

Advanced Auditory Processing Strategies:

Temporal Enhancement Algorithms: Implement in hearing aids or cochlear implants to improve speech perception in noise.

Auditory Training Programs: Targeted exercises to enhance temporal processing abilities 16 19.

Specialist Referral

Genetic Counseling: For families with a history of ANSD or suspected genetic etiology.

Neurological Evaluation: If associated neurological symptoms are present, to rule out systemic conditions 1 5 25.

Contraindications:

Cochlear implantation may be contraindicated in cases with significant cochlear nerve deficiency or structural abnormalities 8 21.

Complications

Acute Complications

Delayed Language Development: Prolonged difficulties in acquiring speech and language skills.

Educational Challenges: Struggles in academic performance due to hearing deficits.

Long-Term Complications

Social Isolation: Potential for reduced social interaction and emotional well-being.

Cognitive Impairment: In severe cases, long-term cognitive deficits may arise from chronic auditory deprivation 11 24.

Management Triggers

Inadequate Early Intervention: Delays in therapy and support can exacerbate developmental delays.

Suboptimal Amplification: Ineffective hearing aid settings or inappropriate device selection can hinder progress 17 33.

Prognosis & Follow-Up

The prognosis for individuals with ANSD varies widely depending on the severity of neural impairment and the timeliness and effectiveness of interventions. Positive prognostic indicators include:

Early diagnosis and intervention

Successful use of cochlear implants

Consistent participation in auditory-verbal therapy

Recommended Follow-Up Intervals:

Initial Phase (0-2 years): Monthly audiological assessments and therapy sessions.

Intermediate Phase (2-5 years): Every 3-6 months to monitor progress and adjust interventions.

Long-Term (5+ years): Annually to evaluate speech development, academic performance, and hearing aid/implant efficacy 11 24.

Special Populations

Pediatrics

Early identification and intervention are critical in pediatric patients to mitigate developmental delays. Cochlear implantation and intensive auditory-verbal therapy are often recommended 9 11 27.

Genetic Considerations

Families with a history of ANSD should undergo genetic counseling and testing, particularly for mutations in OTOF and PJVK genes 1 28 30.

Comorbidities

Children with ANSD and associated conditions like neurological syndromes (e.g., Brown-Vialetto-Van Laere syndrome) require multidisciplinary care addressing both hearing impairment and systemic issues 36.

Key Recommendations

Genetic Testing: Offer genetic testing for OTOF and PJVK mutations in patients with suspected ANSD (Evidence: Moderate) 1 28.

Comprehensive Audiological Evaluation: Include OAEs, CMs, ABRs, and temporal processing tests in the diagnostic workup (Evidence: Strong) 3 6.

Early Intervention: Initiate auditory-verbal therapy and appropriate amplification (hearing aids or cochlear implants) within the first 6 months of diagnosis (Evidence: Strong) 11 9.

Specialized Amplification Strategies: Use low-cut filters and temporal enhancement algorithms in hearing aids for optimal benefit (Evidence: Moderate) 16 19.

Regular Monitoring: Schedule follow-up assessments every 3-6 months in the first few years, then annually thereafter (Evidence: Expert opinion) 11 24.

Multidisciplinary Approach: Involve audiologists, speech therapists, genetic counselors, and neurologists as needed (Evidence: Expert opinion) 1 5 25.

Consider Cochlear Implantation: For severe cases unresponsive to hearing aids, evaluate cochlear implantation early (Evidence: Moderate) 9 22.

Family Support and Counseling: Provide psychological support and genetic counseling to families (Evidence: Expert opinion) 1 28.

Language and Cognitive Support: Implement targeted educational strategies to address language and cognitive development (Evidence: Moderate) 11 27.

Evaluate for Cochlear Nerve Deficiency: Perform imaging studies if cochlear implantation is considered to assess nerve integrity (Evidence: Moderate) 8 21.

References

1 Tang F, Ma D, Wang Y, Qiu Y, Liu F, Wang Q et al.. Novel compound heterozygous mutations in the OTOF Gene identified by whole-exome sequencing in auditory neuropathy spectrum disorder. BMC medical genetics 2017. link 2 Wang S, Dong R, Liu D, Wang Y, Liu B, Zhang L et al.. The Role of Temporal Envelope and Fine Structure in Mandarin Lexical Tone Perception in Auditory Neuropathy Spectrum Disorder. PloS one 2015. link 3 He S, Grose JH, Teagle HF, Woodard J, Park LR, Hatch DR et al.. Gap detection measured with electrically evoked auditory event-related potentials and speech-perception abilities in children with auditory neuropathy spectrum disorder. Ear and hearing 2013. link 4 Runge CL, Jensen J, Friedland DR, Litovsky RY, Tarima S. Aiding and occluding the contralateral ear in implanted children with auditory neuropathy spectrum disorder. Journal of the American Academy of Audiology 2011. link 5 Wang J, Fan YY, Wang SJ, Liang PF, Wang JL, Qiu JH. Variants of OTOF and PJVK genes in Chinese patients with auditory neuropathy spectrum disorder. PloS one 2011. link 6 Sharma A, Cardon G, Henion K, Roland P. Cortical maturation and behavioral outcomes in children with auditory neuropathy spectrum disorder. International journal of audiology 2011. link 7 Duarte JL, Araújo ES, Silveira AG, Yamaguti EH, Oliveira EB, Sordi Silva BC et al.. Utility of auditory steady-state response in differentiating pediatric auditory neuropathy spectrum disorders: with normal auditory nerve diameter versus with auditory nerve hypoplasia. International journal of pediatric otorhinolaryngology 2025. link 8 O'Rourke SP, Vos TG, Park LR, Culbertson S, Brown KD. Incidence of Cochlear Nerve Deficiency in Unilateral Pediatric Auditory Neuropathy Spectrum Disorder. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2025. link 9 Kowkuntla S, Cathers P, Chisolm P, Geng X, Jones L, Hoa M. Outcomes of Cochlear Implantation in Adolescents With Auditory Neuropathy Spectrum Disorder: Scoping Review and Case Report. The Annals of otology, rhinology, and laryngology 2025. link 10 Spyridakou C, Chan J, Tan J, Clement E, Nash R, Hall A et al.. Preparing for Otoferlin gene therapy trials: A survey of NHS Paediatric Audiology and Cochlear Implant services on diagnosis and management of Auditory Neuropathy Spectrum Disorder. International journal of pediatric otorhinolaryngology 2024. link 11 Morlet T, O'Reilly R, Pritchett C, Venskytis E, Parkes W. A 15-year Review of 260 Children With Auditory Neuropathy Spectrum Disorder: II. Management and Outcomes. Ear and hearing 2023. link 12 Cooper HE, Halliday LF, Bamiou DE, Mankad K, Clark CA. Brain structure correlates with auditory function in children diagnosed with auditory neuropathy spectrum disorder. Brain and behavior 2022. link 13 Crispo M, Chenouard V, Dos Santos-Neto P, Tesson L, Souza-Neves M, Heslan JM et al.. Generation of a Human Deafness Sheep Model Using the CRISPR/Cas System. Methods in molecular biology (Clifton, N.J.) 2022. link 14 Prabhu P, Joshi K, Muhammad JK, Nisha KV. Contralateral Suppression of Spontaneous Otoacoustic Emissions in Individuals With Auditory Neuropathy Spectrum Disorder. The journal of international advanced otology 2021. link 15 Myers K, Nicholson N. Cochlear Implant Behavioral Outcomes for Children With Auditory Neuropathy Spectrum Disorder: A Mini-Systematic Review. American journal of audiology 2021. link 16 Vijayasarathy S, Shetty HN. Perception of temporally enhanced and hearing aid processed speech in children with late-onset Auditory Neuropathy Spectrum Disorder. International journal of pediatric otorhinolaryngology 2021. link 17 Sbeih F, Goldberg DM, Liu S, Lee MY, Stillitano G, Appachi S et al.. Auditory testing outcomes with hearing aids in patients with auditory neuropathy spectrum disorder. American journal of otolaryngology 2021. link 18 Zhai R, Feng H, Li Q, Lu W, Liu D, Tian Y et al.. Auditory Neuropathy Spectrum Disorder (ANSD)-Clinical Characteristics and Pathogenic Variant Analysis of Three Nonsyndromic Deafness Families. BioMed research international 2020. link 19 Jaisinghani P, Manjula P. Acoustical and Perceptual Analysis of Noise Reduction Strategies in Individuals With Auditory Neuropathy Spectrum Disorders. Journal of speech, language, and hearing research : JSLHR 2020. link 20 Kumar P, Sanju HK, Hussain RO, Kaverappa Ganapathy M, Singh NK. Utility of Acoustic Change Complex as an Objective Tool to Evaluate Difference Limen for Intensity in Cochlear Hearing Loss and Auditory Neuropathy Spectrum Disorder. American journal of audiology 2020. link 21 Lin PH, Hsu CJ, Lin YH, Lin YH, Yang SY, Yang TH et al.. An integrative approach for pediatric auditory neuropathy spectrum disorders: revisiting etiologies and exploring the prognostic utility of auditory steady-state response. Scientific reports 2020. link 22 Kumar P, Sanju HK, Singh NK. Neural representation of consonant-vowel transition in individuals with cochlear hearing loss and auditory neuropathy spectrum disorder. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2020. link 23 Brough H. Acquired auditory neuropathy spectrum disorder after malaria treated with quinine. Tropical doctor 2020. link 24 Ehrmann-Müller D, Back D, Kühn H, Hagen R, Shehata-Dieler W. Long-term treatment outcomes in children with auditory neuropathy spectrum disorder (ANSD). International journal of pediatric otorhinolaryngology 2020. link 25 Harper JL, Wilson TE, Mitchell RM. Case report of two children with auditory neuropathy spectrum disorder related to a neurofascin (NFASC) gene variant. International journal of pediatric otorhinolaryngology 2020. link 26 Qiu Y, Chen S, Xie L, Xu K, Lin Y, Bai X et al.. Auditory Neuropathy Spectrum Disorder due to Two Novel Compound Heterozygous . Neural plasticity 2019. link 27 Merlin AMB, Almeida-Verdu ACM, Neves AJD, Silva LTDN, Moret ALM. Multiple exemplar instruction and integration of listening and speaking behaviors with substantive-adjective syntactic units in children with ANSD and CI. CoDAS 2019. link 28 Kim BJ, Jang JH, Han JH, Park HR, Oh DY, Lee S et al.. Mutational and phenotypic spectrum of OTOF-related auditory neuropathy in Koreans: eliciting reciprocal interaction between bench and clinics. Journal of translational medicine 2018. link 29 Chen K, Liu M, Wu X, Zong L, Jiang H. Targeted next generation sequencing reveals OTOF mutations in auditory neuropathy spectrum disorder. International journal of pediatric otorhinolaryngology 2018. link 30 El-Badry MM, Gamal R, Fawzy A. Evaluation of saccular and inferior vestibular nerve function in children with auditory neuropathy spectrum disorder. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2018. link 31 James AL, Dixon PR, Harrison RV. Cochlear Nerve Aplasia with Detectable Olivocochlear Efferent Function: A Distinct Presentation of Auditory Neuropathy Spectrum Disorder. Audiology & neuro-otology 2018. link 32 Daneshi A, Mirsalehi M, Hashemi SB, Ajalloueyan M, Rajati M, Ghasemi MM et al.. Cochlear implantation in children with auditory neuropathy spectrum disorder: A multicenter study on auditory performance and speech production outcomes. International journal of pediatric otorhinolaryngology 2018. link 33 Prabhu P, Barman A. Effectiveness of low-cut modified amplification strategy and channel-free hearing aid in individuals with auditory neuropathy spectrum disorder. International journal of audiology 2017. link 34 Mathai JP, Yathiraj A. Performance-Intensity Function and Aided Improvement in Individuals With Late-Onset Auditory Neuropathy Spectrum Disorder. Ear and hearing 2017. link 35 Fernandes NF, Yamaguti EH, Morettin M, Costa OA. Speech perception in users of hearing aid with auditory neuropathy spectrum disorder. CoDAS 2016. link 36 Menezes MP, O'Brien K, Hill M, Webster R, Antony J, Ouvrier R et al.. Auditory neuropathy in Brown-Vialetto-Van Laere syndrome due to riboflavin transporter RFVT2 deficiency. Developmental medicine and child neurology 2016. link 37 Wang L, Guan J, Wang H, Lan L, Zhang Q, Zong L et al.. Understanding auditory neuropathy spectrum disorder: a systematic review in transgenic mouse models. Science China. Life sciences 2016. link 38 Mathai JP, Appu S. Perception of Hearing Aid-Processed Speech in Individuals with Late-Onset Auditory Neuropathy Spectrum Disorder. Journal of the American Academy of Audiology 2015. link 39 Declau F, Boudewyns A, Van den Ende J, van de Heyning P. Auditory neuropathy: a challenge for diagnosis and treatment. B-ENT 2013. link 40 Caldas FF, de Castro Silva IM, Teixeira MS, Deperon TM, Cardoso CC, Barreto MA et al.. Auditory neuropathy spectrum: the importance of adequate diagnosis. The international tinnitus journal 2012. link 41 Costa NT, Martinho-Carvalho AC, Cunha MC, Lewis DR. Auditory and communicative abilities in the auditory neuropathy spectrum disorder and mutation in the Otoferlin gene: clinical cases study. Jornal da Sociedade Brasileira de Fonoaudiologia 2012. link 42 Alvarenga KF, Amorim RB, Agostinho-Pesse RS, Costa OA, Nascimento LT, Bevilacqua MC. Speech perception and cortical auditory evoked potentials in cochlear implant users with auditory neuropathy spectrum disorders. International journal of pediatric otorhinolaryngology 2012. link

Auditory neuropathy, optic atrophy syndrome